Cargando…
Mental Health Symptom Reduction Using Digital Therapeutics Care Informed by Genomic SNPs and Gut Microbiome Signatures
Neuropsychiatric diseases and obesity are major components of morbidity and health care costs, with genetic, lifestyle, and gut microbiome factors linked to their etiology. Dietary and weight-loss interventions can help improve mental health, but there is conflicting evidence regarding their efficac...
Autores principales: | Pedroso, Inti, Kumbhare, Shreyas Vivek, Joshi, Bharat, Saravanan, Santosh K., Mongad, Dattatray Suresh, Singh-Rambiritch, Simitha, Uday, Tejaswini, Muthukumar, Karthik Marimuthu, Irudayanathan, Carmel, Reddy-Sinha, Chandana, Dulai, Parambir S., Sinha, Ranjan, Almonacid, Daniel Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409755/ https://www.ncbi.nlm.nih.gov/pubmed/36013186 http://dx.doi.org/10.3390/jpm12081237 |
Ejemplares similares
-
Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study
por: Kumbhare, Shreyas V., et al.
Publicado: (2022) -
Leveraging Genomic Associations in Precision Digital Care for Weight Loss: Cohort Study
por: Sinha, Ranjan, et al.
Publicado: (2021) -
Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020) -
Computational Biology
of BRCA2 in Male Breast Cancer,
through Prediction of Probable nsSNPs, and Hit Identification
por: Shinde, Sangita Dattatray, et al.
Publicado: (2022) -
Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn’s Disease
por: Dulai, Parambir S, et al.
Publicado: (2022)